With more than 80 branch locations and over 50 infusion suites throughout the United States, Coram has expertise in specialty pharmaceutical distribution and home infusion services. It manages nearly 2,000 employees and serves approximately 17,000 patients every month. Operational for more than 20 years, the company is nationally certified by the Accreditation Commission for Health Care. Coram offers drug development and commercialization solutions and serves patients with acute and long-term chronic conditions. Its specialty pharmacy unit, CoramRx, provides drug delivery and clinical management services for specialty injectable, infused and oral medications. The company, through Coram Clinical Trials, participates in clinical research studies and offers in-home nursing assessments and procedures. Its Nourish Nutrition Support Program includes home parenteral and enteral support for individuals who cannot consume nutrients through regular food intake. The company is a provider of Aralast and Zemaira therapies that help in the treatment of antitrypsin deficiency. Its infusion suites offer specialized care services for multiple sclerosis, rheumatoid arthritis and immune deficiencies. The company is one of the largest commercial providers of intravenous immunoglobulin in the U.S. It works in affiliation with several medical practitioners, health care institutions, insurance companies and drug manufacturers. Coram is a part of Apria Healthcare, which is one of the leading providers of home health care products and services in the United States.

Waclawek, Justin

Feneziani, Michael

Holmes, Sarah Lynn

Speier, David, K